The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
about
Disruptive chemicals, senescence and immortalityCell senescence in myxoid/round cell liposarcomaMechanisms of chromosomal instability in melanoma.EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.miR-22 represses cancer progression by inducing cellular senescencePP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cellsInvolvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.P16/p53 expression and telomerase activity in immortalized human dental pulp cells.Molecular damage in cancer: an argument for mTOR-driven agingEffects of p21 Gene Down-Regulation through RNAi on Antler Stem Cells In VitroAutophagy-independent senescence and genome instability driven by targeted telomere dysfunction.Both Complexity and Location of DNA Damage Contribute to Cellular Senescence Induced by Ionizing Radiation.A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell linesNectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma.Effective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell linesPI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanomaA prognostic signature of G(2) checkpoint function in melanoma cell lines.Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence.Mechanisms of radiation toxicity in transformed and non-transformed cellsOncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.Pathways of oncogene-induced senescence in human melanocytic cellsCellular senescence as a target in cancer control.Narrowing the knowledge gaps for melanomaControversial aspects of oncogene-induced senescence.DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.The Intricate Interplay between Mechanisms Underlying Aging and Cancer.Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.Phenotype-independent effects of retroviral transduction in human dental pulp stem cells.Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion.The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.Nevus senescence.Integration of ALV into CTDSPL and CTDSPL2 genes in B-cell lymphomas promotes cell immortalization, migration and survival.Pathways from senescence to melanoma: focus on MITF sumoylation.Telomerase expression in amyotrophic lateral sclerosis (ALS) patients.
P2860
Q27026235-CCD1E9BC-37D8-4959-8F8A-99A33817A965Q33893832-5842B25D-B6F7-4B50-8EF6-2F142B36F114Q34026182-0B67BA1A-DBA1-4A71-9E8F-E4709F32BFFBQ34803805-727C001D-53D6-46A3-9E08-C656C7F475FAQ34825182-F8641EDC-E405-4794-8D1A-53D3D154C6FAQ35541658-8F3FEEF4-9323-41F3-AB66-2991C90EE245Q35556981-28667C82-27FC-4AFF-BD0C-49F087BEF7E4Q35640301-7800A992-B374-4684-8F37-921E9A2CF589Q35694629-05B590B1-9141-40E8-BF68-BAEFD6F7B747Q35740772-1E159D51-E6B9-4265-997A-DBBB35BE1208Q35755632-B927D63F-FF1A-4BFD-9984-3778D15450F1Q35853227-A1CA4384-7808-43F7-9C39-F056AA438661Q36019964-456B0F9F-9BCB-4A8C-8DA8-5EF48350D856Q36096818-0DD307F1-AA18-426D-ABFC-2CEED51D1633Q36339260-4CA169C2-AEA2-4DAA-A22C-2E4400121D23Q36556389-DD84AB22-40B1-449D-98AC-9BD26655F4CDQ36652026-9D16DBEE-A5A1-4D33-833A-A8E65DCF3616Q36823687-7FE0CF63-9B36-4DEF-8F33-C08D6281F26AQ37138585-450E1CE1-4ABA-4065-B0AA-3E31B66ECF43Q37139115-00250499-5C01-4610-9FCF-3C67CF0042BDQ37210779-B2521AFD-28E3-40AB-8F9E-7935101C4358Q37777015-2F83341B-1E97-4135-9F89-DC2C25D9276FQ37828383-AC07C447-3241-4BD8-B2E4-8555D4C79730Q37984547-90E202C2-B1F1-4368-A356-B7A781D7809DQ38055308-A3702E56-9848-4E82-AA66-5C5FC1F006B9Q38120311-41DEE87A-5AE9-4FC1-B338-49636C71F0AAQ38346325-225AA2AB-A8E1-4D6B-B95B-14A01985E428Q38430876-43413872-B86E-41B5-B9C5-4B17316CDD2FQ39139826-ABA37108-F7F4-4580-A7B7-E65ADF1E1A2DQ39224402-AD060595-C9F8-4069-8BEF-8BAC853C9D76Q39271171-E031A340-ED2F-4865-AFD6-B1B3DEBD6D41Q40546752-54F67D40-0D22-4146-BC85-520D7FE10E6BQ41342227-ACFE6CCA-C413-4DB8-A76F-D6A1587BE247Q47927484-A21C3716-B1EF-4A8D-A1F5-CE2FE9FFD929Q51702688-5C4AE147-1F38-4E09-B9E6-0A32D71D5238
P2860
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The relative contributions of ...... induced melanocyte senescence.
@ast
The relative contributions of ...... induced melanocyte senescence.
@en
The relative contributions of ...... induced melanocyte senescence.
@nl
type
label
The relative contributions of ...... induced melanocyte senescence.
@ast
The relative contributions of ...... induced melanocyte senescence.
@en
The relative contributions of ...... induced melanocyte senescence.
@nl
prefLabel
The relative contributions of ...... induced melanocyte senescence.
@ast
The relative contributions of ...... induced melanocyte senescence.
@en
The relative contributions of ...... induced melanocyte senescence.
@nl
P2093
P2860
P356
P1433
P1476
The relative contributions of ...... induced melanocyte senescence.
@en
P2093
Lyndee L Scurr
Sebastian Haferkamp
Sieu L Tran
Therese M Becker
P2860
P304
P356
10.18632/AGING.100051
P577
2009-05-16T00:00:00Z